VitalCare Signs LOI for Diabetes Treatment Centers in Indiana: VitalCare Will Open Center in Peru, Indiana for Diabetes Wound
CARSON CITY, Nev. (Business Wire EON) April 29, 2008 -- Jimmy McDougald, CEO of VitalCare, stated, "This is the beginning of our Midwest launch and we are excited to be offering iCAT therapy to diabetics in this region."
Tristan V. Voth-Stonger, MD, Executive Vice President & CMO of VitalCare, has identified the centers (Peru, IN and Indianapolis, IN) and structured the LOI, and stated, "These facilities were handpicked for their strategic locations and capacity for growth."
About VitalCare Diabetes Treatment Centers, Inc.
VitalCare Diabetes Treatment Centers, Inc. is a company specializing in providing Administrative, Marketing, Business Development, Strategic Planning, Clinical Oversight and Clinical Management Services to the Diabetes Healthcare Sector, with an emphasis in bringing "Cutting Edge" medical devices and healthcare services direct to consumers, focusing on an emerging FDA approved, US and European Patented technology and treatment intervention for treating Type 1 and Type 2 Diabetes known as "Intracellular Activation Therapy (iCAT)."
Safe Harbor Statement: Forward-looking statements in this release with respect to VitalCare Diabetes Treatment Centers, Inc.'s business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond VitalCare Diabetes Treatment Centers, Inc.'s control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in VitalCare's filings with the Securities and Exchange Commission.